Weighted Average Number of Shares Outstanding, Basic of HERON THERAPEUTICS, INC. /DE/ from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
HERON THERAPEUTICS, INC. /DE/ quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • HERON THERAPEUTICS, INC. /DE/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 166,707,000, a 9.4% increase year-over-year.
  • HERON THERAPEUTICS, INC. /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 166,707,000, a 9.4% increase from 2024.
  • HERON THERAPEUTICS, INC. /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 152,449,000, a 10% increase from 2023.
  • HERON THERAPEUTICS, INC. /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 138,135,000, a 27% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

HERON THERAPEUTICS, INC. /DE/ Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 166,707,000 +14,258,000 +9.4% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 170,348,000 +17,518,000 +11% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 154,020,000 +1,715,000 +1.1% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 153,490,000 +2,291,000 +1.5% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 152,449,000 +14,314,000 +10% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 152,830,000 +7,840,000 +5.4% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025 2025 Q3
Q2 2024 152,305,000 +32,586,000 +27% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 151,199,000 +31,953,000 +27% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 138,135,000 +29,259,000 +27% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 144,990,000 +33,255,000 +30% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 119,719,000 +17,314,000 +17% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 119,246,000 +17,123,000 +17% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 108,876,000 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 111,735,000 +9,829,000 +9.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 102,405,000 +3,946,000 +4% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 102,123,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 101,906,000 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 98,459,000 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2

HERON THERAPEUTICS, INC. /DE/ Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 166,707,000 +14,258,000 +9.4% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 152,449,000 +14,314,000 +10% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 138,135,000 +29,259,000 +27% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 108,876,000 +108,777,529 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 98,471* 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.